Reduced WWOX protein expression in human astrocytoma (Q46066762)

19 December 2017

title

Reduced WWOX protein expression in human astrocytoma (English)

1 reference

19 December 2017

author name string

William Winardi

1

1 reference

19 December 2017

Cheng-Yu Tsai

2

1 reference

19 December 2017

Wan-Tzu Chen

3

1 reference

19 December 2017

Hung-Pei Tsai

4

1 reference

19 December 2017

Chia-Li Chung

5

1 reference

19 December 2017

Jong-Kim Loh

6

1 reference

19 December 2017

Chee-Yin Chai

7

1 reference

19 December 2017

Aij-Lie Kwan

8

1 reference

19 December 2017

publication date

16 May 2013

1 reference

19 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Neuropathology

1 reference

19 December 2017

volume

33

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

621-627

1 reference

19 December 2017

Fragile sites and human disease

cites work

1 reference

Mechanisms of common fragile site instability.

21 January 2018

1 reference

Characterization of a novel protein-binding module--the WW domain

21 January 2018

1 reference

WWOX gene and gene product: tumor suppression through specific protein interactions

21 January 2018

1 reference

Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase

21 January 2018

1 reference

Physical association with WWOX suppresses c-Jun transcriptional activity

21 January 2018

1 reference

WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus

21 January 2018

1 reference

Functional association between Wwox tumor suppressor protein and p73, a p53 homolog

21 January 2018

1 reference

WOX1 is essential for tumor necrosis factor-, UV light-, staurosporine-, and p53-mediated cell death, and its tyrosine 33-phosphorylated form binds and stabilizes serine 46-phosphorylated p53.

21 January 2018

1 reference

p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach?

21 January 2018

1 reference

WWOX in biological control and tumorigenesis

21 January 2018

1 reference

Targeted deletion of Wwox reveals a tumor suppressor function

21 January 2018

1 reference

Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.

21 January 2018

1 reference

The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma

21 January 2018

1 reference

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

21 January 2018

1 reference

A role for the WWOX gene in prostate cancer

21 January 2018

1 reference

The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis

21 January 2018

1 reference

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme

21 January 2018

1 reference

Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer

21 January 2018

1 reference

Role of the WWOX gene, encompassing fragile region FRA16D, in suppression of pancreatic carcinoma cells.

21 January 2018

1 reference

Promoter methylation and the detection of breast cancer

21 January 2018

1 reference

Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/NEUP.12040

1 reference

19 December 2017

1 reference

19 December 2017